NuSkin Enterprises (NUS)
NYSE Markt gesloten
Nu Skin Enterprises, Inc. is a global beauty and wellness company that develops, markets, and sells personal care products, nutritional supplements, and related consumer technologies. The company is best known for the Nu Skin brand, which spans skin care, beauty devices, and anti-aging products, and Pharmanex, its wellness and nutrition line. Its products are distributed internationally through a direct selling model supported by independent sales leaders, social commerce tools, and local market operations.
Nu Skin reports its business across a broad geographic footprint that includes the Americas, Mainland China, Southeast Asia/Pacific, Japan, South Korea, Europe & Africa, and Hong Kong/Taiwan. This structure reflects the company’s reliance on local consumer preferences, regulatory environments, and distributor networks in each region. The Americas segment is a particularly important contributor, and wellness products represent a major part of total revenue.
Beyond its core branded consumer business, Nu Skin operates Rhyz, a strategic investment and operating platform. Rhyz includes manufacturing and packaging assets that support product development and supply chain capabilities, as well as other investments intended to broaden the company’s commercial reach. This gives Nu Skin exposure not only to consumer-facing beauty and wellness categories, but also to parts of the production infrastructure behind them.
The company competes in markets shaped by health-conscious consumers, premium skin care demand, and the growth of digital selling. Its performance depends on product innovation, brand engagement, distributor productivity, and the ability to navigate changing rules for direct selling and consumer products across global markets.
Laatst bijgewerkt
- Marktkapitalisatie
- 258.29M
- K/W
- 4.74
- K/VKF
- 6.21
- K/Omzet
- 0.18
- Enterprise value
- 283.23M
- Bedrijfssector
- Health Care
- Bedrijfstak
- Drugs, Drug Proprietaries, and Druggists' Sundries
- Adres
- 75 WEST CENTER ST, PROVO, UT, 84601
Global Derma Roller Market Size To Worth USD 668.17 Million By 2033 | CAGR OF 8.22%
Nu Skin (NUS) Up 5.6% Since Last Earnings Report: Can It Continue?
Nu Skin (NUS) Q1 Earnings Beat, Revenues Hurt by Currency Woes
Nu Skin Enterprises (NUS) Surpasses Q1 Earnings Estimates
Why Is Inter Parfums (IPAR) Down 4.1% Since Last Earnings Report?
Nu Skin (NUS) Down 7.2% Since Last Earnings Report: Can It Rebound?
Nu Skin (NUS) Q4 Earnings Top Estimates, Revenues Decline Y/Y
Nu Skin Enterprises (NUS) Surpasses Q4 Earnings and Revenue Estimates
Things to Consider Ahead of Nu Skin's (NUS) Q4 Earnings
Philip Morris (PM) Lags Q4 Earnings Estimates
Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for
Nu Skin (NUS) Down More Than 20% in 3 Months: Here's Why
Why Is Inter Parfums (IPAR) Up 2.8% Since Last Earnings Report?
Nu Skin (NUS) Up 1% Since Last Earnings Report: Can It Continue?
Nu Skin (NUS) Misses Q3 Earnings Estimates, Lowers Guidance
Why Nu Skin (NUS) Could Beat Earnings Estimates Again
e.l.f. Beauty (ELF) Readies for Q2 Earnings: Is a Beat Likely?
Things to Note Ahead of Nu Skin's (NUS) Q3 Earnings
Nu Skin Enterprises (NUS) Reports Next Week: Wall Street Expects Earnings Growth
Nu Vision 2025 Strategy Aids Nu Skin (NUS), High Costs Hurt
- Marktkapitalisatie
De marktkapitalisatie is de totale waarde van de aandelen van een bedrijf, berekend door de aandelenkoers te vermenigvuldigen met het aantal uitstaande aandelen.
- 258.29M
- Enterprise value
De enterprise value is de totale waarde van een bedrijf, inclusief marktkapitalisatie, schuld en kas.
- 283.23M
- K/W
De K/W-ratio vergelijkt de aandelenkoers met de winst per aandeel.
- 4.74
- K/Boek
De K/Boek-ratio vergelijkt de aandelenkoers met de boekwaarde per aandeel.
- 0.33
- K/Omzet
De K/Omzet-ratio vergelijkt de aandelenkoers met de omzet per aandeel.
- 0.18
- Ondernemingswaarde / EBITDA
EV/EBITDA meet de waarde van een bedrijf ten opzichte van de winst vóór rente, belastingen, afschrijvingen en amortisatie.
- 2.15
- EV / Omzet
EV/Omzet meet de waarde van een bedrijf ten opzichte van de totale omzet.
- 0.2
- Winst per aandeel
- 1.12
- Dividendrendement
Het dividendrendement laat zien hoeveel een bedrijf jaarlijks aan dividenden uitkeert ten opzichte van de aandelenkoers.
- 7.05%
- K/VKF
De koers/vrije-kasstroom-ratio vergelijkt de aandelenkoers met de kas die overblijft na kosten en investeringen.
- 6.21
- K/KF
De K/KF-ratio vergelijkt de aandelenkoers met de operationele kasstroom.
- 3.4
- Vrije kasstroom
Vrije kasstroom is de kas die overblijft na operationele kosten en kapitaaluitgaven.
- 41.57M
- Rendement op eigen vermogen
ROE meet hoe effectief een bedrijf het eigen vermogen inzet om winst te genereren.
- 6.87%
- Rendement op activa
ROA meet hoe effectief een bedrijf zijn activa inzet om winst te genereren.
- 3.96%
- Schuld / Eigen vermogen
De schuld/eigen-vermogen-ratio vergelijkt de totale schuld met het eigen vermogen.
- 0.28
- Current ratio
De current ratio meet het vermogen om kortlopende schulden te betalen met vlottende activa.
- 2.03
- Quick ratio
De quick ratio meet het vermogen om kortlopende schulden te betalen met kas en snel realiseerbare activa.
- 1.34
- Kas
De kasratio meet het vermogen om kortlopende schulden uitsluitend met kas en kasgelijkwaardigen te dekken.
- 0.77
- Gem. volume
Het gemiddelde volume toont het gemiddelde aantal verhandelde aandelen over de laatste 30 handelsdagen en geeft liquiditeit aan.
- 647.09K
- Fundamentele snapshotprijs
De fundamentele snapshotprijs is de koers die wordt gebruikt bij het berekenen van de financiële ratio's van het bedrijf.
- 5.32
Winst- en verliesrekening
| Post | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Omzet | 320.61M | 370.32M | 364.21M | 386.14M | 364.49M |
| Brutowinst | 214.46M | 261.98M | 256.72M | 265.73M | 246.96M |
| Operationele winst | 4.03M | 23.24M | 21.64M | 30.78M | -9.9M |
| Resultaat vóór rente, belastingen en afschrijvingen | 18.21M | 36.16M | 33.73M | 43.83M | 29.42M |
| Nettowinst | 1.84M | 14.49M | 17.08M | 21.12M | 107.52M |
| Basis EPS | 0.04 | 0.31 | 0.35 | 0.43 | 2.16 |
| Verwaterde EPS | 0.04 | 0.27 | 0.34 | 0.43 | 2.14 |
Balans
| Post | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Totaal activa | 1.38B | 1.41B | 1.42B | 1.44B | 1.39B |
| Totaal passiva | 582.71M | 600.07M | 624.61M | 655.94M | 637.44M |
| Totaal eigen vermogen | 794.09M | 805.24M | 799.8M | 787.75M | 753.97M |
| Kas en equivalenten | 198.65M | 238.63M | 251.79M | 264.16M | 203.77M |
| Vlottende activa | 522.89M | 547.7M | 548.14M | 571.55M | 524.86M |
| Kortlopende passiva | 257M | 263.73M | 254.44M | 283.91M | 260.3M |
Kasstroom
| Post | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operationele kasstroom | -3.92M | 16.62M | 27.48M | 35.8M | 389K |
| Investeringskasstroom | -14.29M | -9.76M | -9.92M | 8.79M | 181.54M |
| Financieringskasstroom | -20.4M | -18.5M | -26.88M | 9.27M | -166.3M |
| Mutatie kas | -39.98M | -13.16M | -12.37M | 60.39M | 16.89M |
| Soort | Deponering | Datum | Koppeling |
|---|---|---|---|
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 144 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| form 4 | Form 4 — Winett James M | Deponering bekijken | |
| edgar index | S-8 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 144 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| form 4 | Form 4 — CAMPBELL DANIEL W | Deponering bekijken | |
| form 4 | Form 4 — CAMPBELL DANIEL W | Deponering bekijken | |
| form 4 | Form 4 — CAMPBELL DANIEL W | Deponering bekijken | |
| form 4 | Form 4 — Thomas Pisano R. | Deponering bekijken | |
| form 4 | Form 4 — Battle Emma S. | Deponering bekijken | |
| form 4 | Form 4 — WOODBURY EDWINA D | Deponering bekijken | |
| form 4 | Form 4 — WOODBURY EDWINA D | Deponering bekijken | |
| form 4 | Form 4 — Zorko Mark A | Deponering bekijken | |
| form 4 | Form 4 — Nathanson Laura | Deponering bekijken | |
| form 4 | Form 4 — Winett James M | Deponering bekijken | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| eight k text | 8-K — 8-K | Deponering bekijken | |
| edgar index | SD — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 144 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| form 4 | Form 4 — Nathanson Laura | Deponering bekijken | |
| edgar index | 10-Q — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| eight k text | 8-K — 8-K | Deponering bekijken | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| eight k text | 8-K — 8-K | Deponering bekijken | |
| edgar index | DEF 14A — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | DEFA14A — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | ARS — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 3 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| form 3 | Form 3 — Lantz Chelsea K | Deponering bekijken | |
| edgar index | SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| eight k text | 8-K — 8-K | Deponering bekijken | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| eight k text | 8-K — 8-K | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| form 4 | Form 4 — WOODBURY EDWINA D | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| eight k text | 8-K — 8-K | Deponering bekijken | |
| form 4 | Form 4 — NAPIERSKI RYAN S | Deponering bekijken | |
| form 4 | Form 4 — Thomas James D | Deponering bekijken | |
| form 4 | Form 4 — Clark Chayce David | Deponering bekijken | |
| form 4 | Form 4 — Hatchett Steven Keith | Deponering bekijken | |
| form 4 | Form 4 — Keisel Justin S | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| form 4 | Form 4 — NAPIERSKI RYAN S | Deponering bekijken | |
| form 4 | Form 4 — Thomas James D | Deponering bekijken | |
| form 4 | Form 4 — Clark Chayce David | Deponering bekijken | |
| form 4 | Form 4 — Hatchett Steven Keith | Deponering bekijken | |
| form 4 | Form 4 — Keisel Justin S | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Deponering bekijken | |
| form 4 | Form 4 — NAPIERSKI RYAN S | Deponering bekijken | |
| form 4 | Form 4 — Thomas James D | Deponering bekijken | |
| form 4 | Form 4 — Clark Chayce David | Deponering bekijken |